share_log

Top 3 Health Care Stocks That Are Set To Fly This Quarter

Top 3 Health Care Stocks That Are Set To Fly This Quarter

前三家醫療保健股票在本季度有望上漲
Benzinga ·  08/16 19:57

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

醫療保健板塊中最超賣的股票爲買入被低估的公司提供了機會。

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

RSI指標是一種動量指標，它比較了股票在價格上漲時的強度與在價格下跌時的強度。與股票的價格走勢進行比較，可以給交易者更好的了解股票短期內表現的良好程度。當RSI低於30時，資產通常被認爲是超賣的，根據Benzinga Pro的數據。

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

以下是本行業板塊最近的主要超賣股票列表，RSI接近或低於30。

Haemonetics Corporation (NYSE:HAE)

美國血液技術公司（NYSE：HAE）

  • On Aug. 8, Haemonetics posted better-than-expected quarterly earnings. The company's stock fell around 19% over the past month and has a 52-week low of $70.74.
  • RSI Value: 25.47
  • HAE Price Action: Shares of Haemonetics gained 1.1% to close at $73.99 on Thursday.
  • Benzinga Pro's real-time newsfeed alerted to latest HAE news.
  • 8月8日，美國血液技術公司發佈了好於預期的季度業績，該公司的股票在過去一個月下跌了約19%，52周最低股價爲70.74美元。
  • RSI數值：25.47
  • 美國血液技術公司股票價格變化：週四，美國血液技術公司的股票上漲了1.1%，收於73.99美元。
  • Benzinga Pro的實時新聞提醒了最新的美國血液技術公司新聞。
big

Immunitybio Inc (NASDAQ:IBRX)

Immunitybio Inc（NASDAQ：IBRX）

  • On Aug. 6, ImmunityBio announced study of ANKTIVA in combination with the AdHER2DC cancer vaccine as a potential therapy to control endometrial cancer. The company's stock fell around 38% over the past month. It has a 52-week low of $1.25.
  • RSI Value: 29.87
  • IBRX Price Action: Shares of Immunitybio rose 2.6% to close at $3.98 on Thursday.
  • Benzinga Pro's charting tool helped identify the trend in IBRX stock.
  • 8月6日，ImmunityBio宣佈了ANKTIVA與AdHER2DC癌症疫苗聯合治療子宮內膜癌的研究作爲一種潛在的治療方案。 該公司的股票在過去一個月下跌了約38％，52周最低股價爲1.25美元。
  • RSI數值：29.87
  • Immunitybio股票價格變化：週四，Immunitybio的股票上漲了2.6％，收於3.98美元。
  • Benzinga Pro的圖表工具幫助識別IBRX股票的趨勢。
big

Progyny Inc (NASDAQ:PGNY)

Progyny Inc（NASDAQ：PGNY）

  • On Aug. 6, Progyny reported worse-than-expected second-quarter revenue results. "The rate of utilization in the second quarter was consistent with our expectations, indicating that the demand for treatment remains both healthy and within the range of our long-established patterns," said Pete Anevski, Chief Executive Officer of Progyny. The company's shares fell around 31% over the past month and has a 52-week low of $19.60.
  • RSI Value: 29.06
  • PGNY Price Action: Shares of Progyny rose 1.7% to close at $20.85 on Thursday.
  • Benzinga Pro's signals feature notified of a potential breakout in PGNY shares.
  • 8月6日，Progyny公佈了不如預期的第二季度營業收入結果。 「第二季度利用率率與我們的預期一致，表明治療需求仍保持健康並符合我們長期建立的模式。」 Pete Anevski，Progyny的首席執行官說。該公司的股票在過去一個月下跌了約31％，52周最低股價爲19.60美元。
  • RSI數值：29.06
  • Progyny股票價格變化：週四，Progyny的股票上漲了1.7％，收於20.85美元。
  • Benzinga Pro的信號功能提示了PGNY股票的潛在突破。
big
  • Jim Cramer Recommends Buying Clorox: 'CEO Has Done Remarkable Job'
  • 吉姆·克萊默推薦購買高樂氏：'CEO表現出色'

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論